Skip to search formSkip to main contentSkip to account menu

Refractory Non-Hodgkin Lymphoma

Known as: Non-Hodgkin's Lymphoma Refractory, NonHodgkin's Lymphoma Refractory, Refractory Non-Hodgkin's Lymphoma 
A non-Hodgkin lymphoma which does not respond to treatment.
National Institutes of Health

Related topics

Related topics

16 relations
Atypical lymphocyteDHAP RegimenESHAP regimenHematopoietic and Lymphoid Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma
Abstract B-cell non-Hodgkin lymphomas (NHL) display dysregulation of pathways controlling cell proliferation and apoptosis… 
2017
2017
[Efficacy Analysis of GEMOX Regimen for Treatment of Refractory Non-Hodgkin's Lymphoma].
OBJECTIVE To explore the clinical efficacy of GEMOX regimen on patients with refractory non-hodgkin's lymphoma. METHODS Eighty… 
2012
2012
Clinical observation of GLD regimen ( gemcitabin,oxaliplatin,and dexamethason) in treatment of relapsed or refractory non-hodgkin's lymphoma
Objective:To evaluate the effect and toxicity of gemcitabine combined with oxaliplatin and dexamethasone in the treatment of… 
2009
2009
Efficacy of DICE regimen on relapsed and refractory non-hodgkin's lymphoma
OBJECTIVE:To evaluate the efficacy and adverse events of DICE((Dexamethasone,Etoposide,Ifosfamide,and Cisplatin) regimen on… 
2006
2006
Yttrium-90 (90Y) ibritumomab tiuxetan for treatment of relapsed or refractory non-hodgkin's lymphoma: The Western Pennsylvania Cancer Institute experience.
12511 Background: Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) radioimmunotherapy is an effective agent for treatment of CD20… 
2004
2004
Zevalin dose-escalation followed by high-dose beam and autotransplant in cd20+ relapsed or refractory non-hodgkin lymphoma (NHL)
1993
1993
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
1989
1989
Prednimustine treatment in malignant lymphomas.
Prednimustine (Stereocyt, Leo 1031) is a chlorambucil ester of prednisolone. Results from clinical trials confirm that… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)